Naloxone nasal spray – New drug approval
March 8, 2023 - Amphastar Pharmaceuticals announced the FDA approval of naloxone nasal spray, for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients.
Top